Global /India /Healthcare /Drug Manufacturers - General /THEMISMED
chevron_leftBack
Themis Medicare Ltd. logo

Themis Medicare Ltd.

THEMISMED
NSE: THEMISMED Delayed
98.70INR 5.3%
1.05 USD
As of 20 June 2026, Themis Medicare Ltd. has a market cap of $91.01M USD, ranking #26228 globally and #1617 in India. It ranks #2349 in the Healthcare sector, and #845 in the Drug Manufacturers - General industry.
Global Rank
26228
Country Rank
1617
Sector Rank
2349
Industry Rank
845
Key Stats
Market Cap
$91.01MUSD
8.59B INR
Enterprise Value
$99.75MUSD
9.42B INR
Revenue (TTM)
$35.75MUSD
3.37B INR
EBITDA (TTM)
-$1.19MUSD
-112.17M INR
Net Income (TTM)
-$1.84MUSD
-174.06M INR
EBITDA Margin
-3.3%
Profit Margin
-5.2%
PS Ratio
2.5
PB Ratio
2.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sachin Patel open_in_new
Employees
1,702
Founded
1952
Website
themismedicare.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
5.3% 1.7% 34% 16% -27% -29%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
THEMISMED
Themis Medicare Ltd
ISIN: INE083B01024
Shares Out.:
92.1M1 Shares Float: 23.129M2
TV:
SA:
YF:
GF:
BA:
MS:
98.70 INR
Bombay Stock Exchange
MIC: XBOM
530199 (THEMISMED)
Themis Medicare Ltd
ISIN: INE083B01024
TV:
SA:
YF:
GF:
BA:
MS:
93.27 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Themis Medicare Ltd.

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, hematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasodilator, vasopressors, and vitamins. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
50K%
39.1
DIVISLAB
$18.38B
1.73T INR
20K%
70.0
$15.17B
1.43T INR
17K%
63.0
$11.73B
1.11T INR
13K%
19.6
MANKIND
$9.87B
931.67B INR
11K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
11K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
837K%
38.1
JNJ
$547.28B
601K%
26.4
ABBV
$360.63B
396K%
97.4
$318.3B
256.25B CHF
350K%
19.9
AZN
$284.64B
215.59B GBP
313K%
27.6
MRK
$274.03B
301K%
15.1
chevron_leftBack